会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 58. 发明申请
    • IL-8 RECEPTOR ANTAGONISTS
    • IL-8受体拮抗剂
    • US20010018447A1
    • 2001-08-30
    • US09508039
    • 2000-03-03
    • KATHERINE L. WIDDOWSONHONG NIE
    • A61K031/425C07D275/04C07D275/06C07D417/00C07D513/00
    • C07D275/06
    • This invention relates to novel compounds of Formula (I), and compositions thereof, useful in the treatment of disease states mediated by the chemokine, Interleukin-8 (IL-8). Compounds of Formnula (I) are represented, interalia, by structure (I) wherein interalia, R is nullNHnullC(X)nullNHnull (CR13R14)vnullZ; Z is optionally substituted phenyl or napthyl, optionally substituted heteroaryl, optionally substituted C5-8 cycloalkyl, optionally substituted C1-10 alkyl, optionally substituted C2-10 alkenyl, or an optionally substituted C2-10 alkynyl; X is nullO, or nullS; A is a mono- or di-substituted carbon as defined herein; v is 0, or an integer having a value of 1 to 4; or a pharmaceutically acceptable salt thereof.
    • 本发明涉及新的式(I)化合物及其组合物,其可用于治疗由趋化因子介导的疾病状态,白细胞介素-8(IL-8)。 式(I)的化合物由式(I)表示,其中杂环,R为-NH-C(X)-NH-(CR 13 R 14)v-Z; Z是任选取代的苯基或萘基,任选取代的杂芳基,任选取代的C 5-8环烷基,任选取代的C 1-10烷基,任选取代的C 2-10烯基或任选取代的C 2-10炔基; X为= O或= S; A是本文定义的单取代或二取代的碳; v为0,或值为1〜4的整数; 或其药学上可接受的盐。